However, glaucoma severity will rather depend on the history of the disease or treatment, further prospective study on analysis between glaucoma progression and ATX and other possible biomarkers with larger subjects will be needed to evaluate the efficacy of biomarkers. The gene discussed is ENPP2; the disease is glaucoma.